You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T Therapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CAR-T Autologous T cell injection
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Dec 2, 2022

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

    Recruiting
    • Diffuse Large-Cell Lymphoma
    • +3 more
    • Pneumococcal conjugate vaccine (PCV13)
    • CD19 targeted CAR T Cell Therapy
    • Tampa, Florida
      Moffitt Cancer Center
    May 31, 2022

    Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

    Recruiting
    • Pancreas Cancer
    • +3 more
    • CAR-T cells
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Mar 10, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    Lymphoma Patients Undergoing CAR-T Cell Therapy: FIL_SAR-CAR

    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • Chimeric Antigen Receptor T-cells (CAR-T) therapy
    • Alessandria, Italy
    • +20 more
    Nov 27, 2023

    Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

    Not yet recruiting
    • Non Hodgkin's Lymphoma
    • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
    • +2 more
    • Beijing, China
    • +2 more
    Aug 23, 2023

    Non-Hodgkin's Lymphoma Trial in Hangzhou (ThisCART19A)

    Recruiting
    • Non-Hodgkin's Lymphoma
    • ThisCART19A
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 21, 2022

    Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

    Recruiting
    • Recurrent Glioblastoma Multiforme
    • SNC-109 CAR-T Cells
    • Beijing, China
      Chinese PLA General Hospital
    May 11, 2023

    Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

    Recruiting
    • Relapsed/Refractory Large B-Cell Lymphoma
    • Prizloncabtagene autoleucel
    • Beijing, China
    • +1 more
    Mar 24, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Anti-GPRC5D CAR-T Cells Injection
    • (no location specified)
    Feb 18, 2023

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    CRC, Solid Tumor Trial in Beijing (KD-025)

    Recruiting
    • CRC
    • Solid Tumor
    • KD-025
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    May 16, 2022

    Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Apr 7, 2023

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    Large B-cell Lymphoma, B-cell Lymphoma Trial in Houston (Magrolimab, Rituximab, CAR T leukapheresis)

    Not yet recruiting
    • Large B-cell Lymphoma
    • B-cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2023

    Metastatic Pancreatic Carcinoma Trial in Providence (CAR2 Anti-CEA CAR-T cells)

    Terminated
    • Metastatic Pancreatic Carcinoma
    • CAR2 Anti-CEA CAR-T cells
    • Providence, Rhode Island
      Roger Williams Medical Center
    Jan 12, 2023

    Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Itacitinib
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 6, 2023

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA CAR-T
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 4, 2023

    Multiple Myeloma Trial in Worldwide (PHE885)

    Recruiting
    • Multiple Myeloma
    • PHE885
    • VIC, Melbourne, Australia
    • +4 more
    Jul 20, 2022

    Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • PK Blood Collection
    • +2 more
    • (no location specified)
    Nov 1, 2022

    Lymphoma, Lymphoma, B-Cell, Leukemia Trial in Houston (Digital Health Coaching)

    Recruiting
    • Lymphoma
    • +6 more
    • Digital Health Coaching
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Apr 12, 2022

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

    Recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Anti-GPRC5D CAR-T cells infusion
    • Kunming, Yunnan, China
    • +1 more
    Feb 21, 2023